Heart Attack Diagnostic Market Value Is Anticipated To Reach $17.89 Billion By 2030, Driven By Key Growth Factors
How Significant Is The Future Market Potential Of The Heart Attack Diagnostic Market Based On Its Projected Size And Growth Rate?
The heart attack diagnostic market size has grown strongly in recent years. It will grow from $11.54 billion in 2025 to $12.64 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of hospital diagnostic capabilities, improved availability of cardiac imaging technologies, increasing awareness of early heart attack detection, advancements in laboratory testing methods.
The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $17.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, growing integration of digital health platforms, expansion of remote cardiac monitoring, rising investments in advanced imaging technologies, increasing adoption of precision cardiology diagnostics. Major trends in the forecast period include increasing adoption of ai-assisted diagnostic tools, rising use of high-sensitivity cardiac biomarkers, growing integration of point-of-care testing devices, expansion of non-invasive diagnostic procedures, enhanced focus on rapid emergency diagnostics.
Claim Your Free Report Sample Today:
Which Major Drivers Are Strengthening Demand In The Heart Attack Diagnostic Market?
The rising prevalence of cardiac disorders is propelling the growth of the heart attack diagnostics market. Cardiac disorders (CVD) are a group of disorders of the heart and blood vessels affecting the heart. Unhealthy eating, inactivity, usage of tobacco products, and abusing alcohol are the main factors for heart disease and stroke. Heart attack diagnosis helps in analyzing the causes and severity of heart attack, stroke, and heart failure. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the heart attack diagnostics market.
How Is The Heart Attack Diagnostic Market Divided Across Its Major Segment Categories?
The heart attack diagnostic market covered in this report is segmented –
1) By Test Type: Electrocardiogram (ECG Or EKG), Blood Tests, Echocardiogram, Coronary Catheterization (Angiogram)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
Subsegments:
1) By Electrocardiogram (ECG Or EKG): Resting ECG, Holter Monitor, Event Monitor
2) By Blood Tests: Cardiac Biomarkers, Lipid Panel, B-Type Natriuretic Peptide (BNP)
3) By Echocardiogram: Transthoracic Echocardiogram (TTE), Transesophageal Echocardiogram (TEE), Doppler Echocardiogram
4) By Coronary Catheterization (Angiogram): Coronary Angiography, Right Heart Catheterization, Left Heart Catheterization
What Major Trends Are Set To Shape The Heart Attack Diagnostic Market Outlook Through The Forecast Period?
Major companies operating in the heart attack diagnostics market are developing innovative products such as coronary heart disease detection tests to meet larger customer bases, more sales, and increase revenue. Coronary heart disease (CHD) detection tests refer to medical assessments and diagnostic procedures designed to identify the presence of coronary heart disease, a condition characterized by the narrowing or blockage of coronary arteries that supply blood to the heart muscle. For instance, in August 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology company, launched PrecisionCHD. The PrecisionCHD test, a groundbreaking innovation, is a blood-based detection method for coronary heart disease (CHD), setting itself apart as the sole detection technology seamlessly combining epigenetic and genetic biomarkers with Artificial Intelligence (AI). This unique test necessitates only a straightforward blood sample, conveniently collected at a doctor's office or through a simple at-home procedure and employs the same highly scalable laboratory technique utilized in COVID-19 testing. With results available for review within a swift 10 business days, the PrecisionCHD test offers a rapid and efficient alternative to traditional first-line CHD detection tools like stress echocardiograms.
Which Influential Players Dominate The Competitive Environment Of The Heart Attack Diagnostic Market?
Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Koninklijke Philips NV, Siemens AG, Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., HeartFlow, Cardio Diagnostics Holdings Inc.
Get Your In-Depth Heart Attack Diagnostic Market Report Now:
Which Regions Stand Out As Major Contributors To Future Demand In The Heart Attack Diagnostic Market?
North America was the largest region in the heart attack diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment